XML 92 R82.htm IDEA: XBRL DOCUMENT v3.23.1
RESEARCH AND DEVELOPMENT EXPENSES (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement [Line Items]      
Research and development expenses $ 3,370 $ 5,949 $ 7,167
Alzheimer's Disease Therapeutics [Member]      
Statement [Line Items]      
Research and development expenses 0 4 0
Anti-Infectives [Member]      
Statement [Line Items]      
Research and development expenses 0 0 4
BPH (Enlarged Prostate) and Prostate Cancer Therapeutics [Member]      
Statement [Line Items]      
Research and development expenses 3,370 5,944 7,162
Tobacco Exposure Tests [Member]      
Statement [Line Items]      
Research and development expenses 0 1 1
Research and Development Program [Member]      
Statement [Line Items]      
Research and development expenses $ 0 $ 0 $ 0